Physician profile
Katrina Bidwell
NPI 1912380536
$14,801.75
in general payments reported to CMS, 2019-2025
23 companies · $1,630 in 2025
The $1,630 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $510 · 2021: $1,187 · 2022: $5,811 · 2023: $2,137 · 2024: $3,284 · 2025: $1,630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,530 · Travel and Lodging: $2,521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,529.84 |
| Travel and Lodging | $2,520.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,065.59 | 2021-2025 | Corevalve Evolut R, Azure Xt Dr Mri Surescan, Linq II |
| Boston Scientific Corporation | $2,062.11 | 2020-2025 | Watchman Flx, Watchman Access System, Avvigo Guidance System |
| Abbott Laboratories | $2,043.00 | 2021-2025 | Amplatzer Talisman, Navitor, Mitraclip |
| Edwards Lifesciences Corporation | $1,541.50 | 2022-2025 | Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $739.61 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Acist Medical Systems, INC. | $375.50 | 2024 | |
| Cardiva Medical, INC. | $363.73 | 2021-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic Vascular, INC. | $359.16 | 2019-2020 | |
| Abiomed | $290.87 | 2024-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $231.59 | 2019-2020 | |
| Philips North America LLC | $200.78 | 2022-2024 | (Ao0) Igt Devices Intracardiac, (Bq9) Coronary Ivus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $121.66 | 2023 | Lifevest |
| Biotronik INC. | $88.04 | 2024-2025 | Biomonitor |
| Novartis Pharmaceuticals Corporation | $74.44 | 2024-2025 | |
| Inari Medical, INC. | $62.46 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $49.34 | 2024 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $25.37 | 2025 | Onpattro |
| Siemens Medical Solutions USA, INC. | $24.54 | 2021 | |
| Penumbra, INC. | $24.18 | 2025 | Indigo System |
| Zoll Medical Corporation | $15.90 | 2024 | Defibrillator |
| Biosense Webster, INC. | $15.04 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.56 | 2025 | |
| Amgen INC. | $12.78 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Bidwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.